European Companies Search Engine

71 EU fundings (€47.1M): EUROlinkCAT: Establishing a linked European Cohort of Children with Congenital Anomalies … BdlYear 2016 EU Research and Innovation programme "Horizon"

Text

Siren 180036048

26/07/2016 EU funding: Bile acid, immune-metabolism, lipid and glucose homeostasis
01/08/2016 EU funding: Shaping of axonal complexity by a dynamic regulation of local metabolic pathways in the developing cortex
19/12/2016 EU funding: The Genetics and Physiology of Growth and Size Determination
12/08/2016 EU funding: TOWARDS A COMPREHENSIVE ANALYSIS OF EXTRACELLULAR SCAFFOLDING AT THE SYNAPSE
20/09/2016 EU funding: Wiring synaptic circuits with astroglial connexins: mechanisms, dynamics and impact for critical period plasticity
11/08/2016 EU funding (€1,255,000): Cofactor Binding Antibodies – Basic Aspects and Therapeutic Innovations
14/12/2016 EU funding (€1,333,718): Tracking information flow in the brain: A unified and general framework for dynamic communication in brain networks
26/05/2016 EU funding (€1,500,000): Cell intrinsic control of CD4 T cell differentiation by cytosolic DNA sensing pathways
01/08/2016 EU funding (€1,899,375): Biological Determinants of ILC Reactivity for Immune Responses in Health and Disease
01/01/2016 EU funding (€1,919,811): Distinctive characterization of regulatory plasma cells and pro-inflammatory B cells in immunity: their origins, molecular properties, and cellular fates.
01/12/2016 EU funding (€1,960,996): Transfer of Organisational innovations for Resilient, Effective, equitable, Accessible, sustainable and Comprehnsive Health Services and Systems.
01/10/2016 EU funding (€1,998,760): NEUROBIOLOGY OF EPILEPSY GENES
15/12/2016 EU funding (€1,999,973): SPIDIA for Personalized Medicine - Standardisation of generic Pre-analytical procedures for In-vitro DIAgnostics for Personalized Medicine
01/04/2016 EU funding (€115,673): Optical strategies to investigate NMDA receptor functional diversity and its therapeutic potential
01/10/2016 EU funding (€12M): A global alliance for Zika virus control and prevention
01/01/2016 EU funding (€14.9M): Ubiquitous Pharmacogenomics (U-PGx): Making actionable pharmacogenomic data and effective treatment optimization accessible to every European citizen
01/01/2016 EU funding (€150,000): Development of immunosuppressive treatments with better safety
07/04/2016 EU funding (€173,076): Going from Phenomenal to Access Consciousness: Neurobehavioural correlates of visual consciousness development and its underlying cognitive procesess.
26/05/2016 EU funding (€173,076): Platelets: at the nexus of brain aneurysm
07/04/2016 EU funding (€185,076): DECIPHERING THE ROLE OF TRIB1 IN REGULATORY T CELLS
07/04/2016 EU funding (€185,076): Dynamics of Attentional Networks in the Human Brain in Health and Disease: Evidence from Intracerebral and MEG Recordings
05/09/2016 EU funding (€185,076): Genetic dissection of the SEMA3C/Neuropilin 1 signalling pathway in Chronic Kidney Disease progression
11/05/2016 EU funding (€185,076): Multimodal Imaging of Disorders of Consciousness
14/12/2016 EU funding (€2,000,000): Defining functional networks of genetic causes for ALS and related neurodegenerative disorders
01/09/2016 EU funding (€2,098,750): Memory and innate-like B-cell subsets: deciphering a multi-layered B-cell response in mice and humans
01/03/2016 EU funding (€2,124,000): Mastiha treatment for healthy obese with NAFLD diagnosis (MAST4HEALTH).
01/10/2016 EU funding (€2,137,828): Expanding and extending gene therapy of monogenic diseases of the haematopoietic system
11/08/2016 EU funding (€2,500,000): NMDA receptor diversity: from molecular dynamics to synaptic physiopathology
01/12/2016 EU funding (€2,569,502): Liaison in Scientific Training for European auditory Neuroscience
01/03/2016 EU funding (€21M): PERtussIS COrrelates of Protection Europe - Sofia ref.: 115910
01/01/2016 EU funding (€22.2M): European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates
16/06/2016 EU funding (€246,668): Biomaterials with incorporated MSC-secreted PARAcrine molecules for bone reGENeration
01/01/2016 EU funding (€3,090,313): PERSONALIZED ENGINE FOR CANCER INTEGRATIVE STUDY AND EVALUATION
23/09/2016 EU funding (€3,202,196): Bioenergetic Remodeling in the Pathophysiology and Treatment of Non-Alcoholic Fatty Liver Disease
19/12/2016 EU funding (€3,296,000): Paediatric Clinical Research Infrastructure Network
01/02/2016 EU funding (€3,340,720): Decision Support and Information Management System for Breast Cancer
01/01/2016 EU funding (€3,497,553): Nano Voltage Sensors
26/09/2016 EU funding (€3,593,489): Scanning probe microscopies for nanoscale fast, tomographic and composition imaging
01/09/2016 EU funding (€3,733,515): Unraveling Principles of PDZ-mediated Cell Signaling
01/01/2016 EU funding (€3,820,896): Sensing and predictive treatment of frailty and associated co-morbidities using advanced personalized patient models and advanced interventions
01/03/2016 EU funding (€3,825,128): Chromatin and Metabolism Chromatin-metabolism interactions as targets for healthy living
23/09/2016 EU funding (€3,924,325): Training, Research and Raising of Public Awareness in Cell Biology and Pathology of Neuroglia
01/03/2016 EU funding (€3,925,589): Studying, Measuring and Altering Consciousness through information theory in the electrical brain
29/11/2016 EU funding (€4,777,258): Optogenetic Protein Therapy for Multiple Sclerosis
19/12/2016 EU funding (€4,955,877): Towards enduring mouse resources and services advancing research into human health and disease
01/01/2016 EU funding (€4,975,862): Data-driven models for Progression Of Neurological Disease
01/01/2016 EU funding (€4,993,834): Folate-Target Nanodevices To Activated Macrophages For Rheumatoid Arthritis
01/05/2016 EU funding (€4,995,000): A Federated Collaborative Care Cure Cloud Architecture for Addressing the Needs of Multi-morbidity and Managing Poly-pharmacy
15/12/2016 EU funding (€49.9M): European Human Biomonitoring Initiative
15/12/2016 EU funding (€5,555,836): REgenerative therapy of intervertebral disc: a double blind phase 2b trial of intradiscal injection of mesenchymal stromal cells in degenerative disc disease of the lomber SPINE unresponsive to conventional therapy
01/01/2016 EU funding (€5,698,310): Mechanisms underlying hepatocellular carcinoma pathogenesis and impact of co-morbidities.
01/01/2016 EU funding (€5,743,160): PROMOTING MENTAL WELLBEING IN THE AGEING URBAN POPULATION: DETERMINANTS, POLICIES AND INTERVENTIONS IN EUROPEAN CITIES
01/01/2016 EU funding (€5,812,631): Imaging the Force of Cancer
01/01/2016 EU funding (€5,989,159): Chimeric Antigen Receptors (CARs) for Advanced Therapies
01/01/2016 EU funding (€5,998,300): Small vessel diseases in a mechanistic perspective: Targets for Intervention Affected pathways and mechanistic exploitation for prevention of stroke and dementia
19/12/2016 EU funding (€5,999,151): ORTHOpedic randomized clinical trial with expanded bone marrow MSC and bioceramics versus autograft in long bone nonUNIONs
22/11/2016 EU funding (€5,999,179): New siRNA Nanotherapy for Inflammatory Bowel Diseases, targeting Janus kinases
01/01/2016 EU funding (€6,134,756): Investigating the impact of meditation training on mental health and wellbeing in the ageing population
15/12/2016 EU funding (€6,193,858): Transcranial brain stimulation as innovative therapy for chronic pediatric neuropsychiatric disorder – STIPED
01/01/2016 EU funding (€6,541,591): Ears, Eyes and Mind: The ‘SENSE-Cog Project’ to improve mental well-being for elderly Europeans with sensory impairment
01/01/2016 EU funding (€6,597,378): Improving Diagnosis by Fast Field-Cycling MRI
01/01/2016 EU funding (€6,926,313): DevelopIng Genetic medicines for Severe Combined Immunodeficiency (SCID)
19/12/2016 EU funding (€7,348,073): EUROlinkCAT: Establishing a linked European Cohort of Children with Congenital Anomalies
01/04/2016 EU funding (€8,130,000): Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification - Sofia ref.: 115881
22/11/2016 EU funding (€8,359,863): High-density cortical implants for cognitive neuroscience and rehabilitation of speech using brain-computer interfaces.
11/11/2016 EU funding (€832,500): Targeting IRE1 in disease
15/12/2016 EU funding (€864,000): Microelements in Life Expectancy and Aging
01/04/2016 EU funding (€89M): Graphene-based disruptive technologies
01/04/2016 EU funding (€89M): Human Brain Project Specific Grant Agreement 1
19/12/2016 EU funding (€9,713,230): RECAP preterm: Research on European Children and Adults born Preterm
15/12/2016 EU funding (€9,957,602): Early-life stressors and LifeCycle health

This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Institut National de la Sante et de la Recherche Medicale, Paris, France.

Creative Commons License The visualizations for "71 EU fundings (€47.1M): EUROlinkCAT: Establishing a linked European Cohort of Children with Congenital Anomalies …" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.